- Presentations
- 4
- Markets
- 1
Cartia XT is a brand of Diltiazem marketed by Actavis Pharma, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Diltiazem
- Brand owner
- Actavis Pharma
- Registered in
- United States
- Strengths and forms
- 120 mg extended-release capsule, 180 mg extended-release capsule, 240 mg extended-release capsule, 300 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cartia XT 120 mg extended-release capsuleOral | Actavis Pharma | US FDA | Available on request |
| Cartia XT 180 mg extended-release capsuleOral | Actavis Pharma | US FDA | Available on request |
| Cartia XT 240 mg extended-release capsuleOral | Actavis Pharma | US FDA | Available on request |
| Cartia XT 300 mg extended-release capsuleOral | Actavis Pharma | US FDA | Available on request |
Equivalent brands
Other brands of Diltiazem.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cartia XT
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.